Light Horse Therapeutics
lighthorsetx.com
Actively hiring
Biotechnology
Medical AI
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Taiho Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Taiho Ventures Similar startupsby what they do, their industry and backers
The only integrated full-stack AI platform for small molecule drug discovery.
Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled…
Variational AI is a Canadian technology company founded in 2019 and based in Vancouver. It builds generative models that design small…
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.
Iktos combines generative AI, retrosynthesis and robotics to accelerate small-molecule drug discovery from design to preclinical candidate…
Overview
Light Horse is a small molecule drug discovery company that is leading the way in a.
News
Light Horse Therapeutics selected by BioSpace as one of the hottest new life sciences companies in the United States for 2026
We are excited to share that BioSpace has selected Light Horse Therapeutics as one of its 15 NextGen: Class of 2026 - top life sciences startups to watch this year.
Read more
Report
Light Horse Therapeutics selected by the American Chemical Society as one of the 10 Start-ups to Watch
We are excited to share that Chemical & Engineering News has selected Light Horse Therapeutics as one of its 10 Start-Ups to Watch. The article explores how our function-first discovery platform scans entire proteins with CRISPR base editing to pinpoint t
Read more
Report
Light Horse Therapeutics Debuts With $62 Million Series A Financing
Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by founding investor Versant Ventures and included Mubadala Capital as well as three strategi
Read more
Report
Light Horse Therapeutics Enters Into Strategic Collaboration With Novartis
SAN DIEGO-(BUSINESS WIRE)-Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, announced a multi-target collaboration with Novartis to identify and develop potentially first-in-class therapeutics using the biotech's pl
Read more
Report